R&D US vs EU: How can Europe translate home-grown innovation int... We have seen a boom in biotech initial public offerings over the last two years, but many of Europe’s offerings have migrated to the United States.
News Non-profit DNDi preps phase 3 trials for dengue antibody Non-profit DNDi has licensed a dengue therapy from India's SII, paving the way for a phase 3 trial in Malaysia, Thailand, and Brazil.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.